Form 4: NeuroPace Executive Reports Stock Transaction
Insider Transaction (Form 4)
Martha Morrell, CHIEF MEDICAL OFFICER of NeuroPace Inc, reported a transaction in 358 shares of common stock on August 27, 2026.
Summary
- Tax/exercise-price withholding: disposed of 358 Common Stock at $14.13 ($5,059) on August 27, 2026; holds 51,692 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Martha Morrell — Officer (CHIEF MEDICAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Tax/exercise-price withholding | Common Stock | 358 | $14 | $5.1K | 51,692 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Tax/exercise-price withholding (358 shares) |
Keywords
insider transaction, Form 4, NPCE, NeuroPace Inc, neutral, Martha Morrell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.